ABSTRACT
Migraine headache (MH) is a chronic, often incapacitating condition that afflicts approximately 28 million Americans (12% of the population), disproportionately affecting more females (18%) than males (6%) (1,2). One out of every four households has someone who is plagued with migraines, interfering not only with his or her job performance, but also interpersonal relationships, and social outings (1). This translates to a collective loss of 112 million workdays and $14 billion in productivity, creating a significant public burden (3). Nevertheless, this condition remains largely under diagnosed and undertreated.
